Trastornos de hipopigmentación en adultos: generalidades y diagnósticos diferenciales
Palabras clave:
hipopigmentación, despigmentación, trastornos adquiridos.Resumen
Las lesiones hipopigmentadas y despigmentadas constituyen un grupo heterogéneo de enfermedades dermatológicas que pueden ser localizadas o generalizadas. Los dermatólogos deben estar familiarizados con los diagnósticos diferenciales, incluyendo las lesiones malignas o benignas de piel con manifestación leucodérmica, y no olvidar el enfoque sistémico del paciente y el uso de las herramientas de apoyo diagnóstico
Biografía del autor/a
Claudia Juliana Díaz
Médica dermatóloga; docente, Escuela de Dermatología y Cirugía Dermatológica, Facultad de Salud, Universidad del Valle, Cali, Colombia
Referencias bibliográficas
1. Tey HL. Approach to hypopigmentation disorders in adults. Clin Exp Dermatol. 2010;35:829-34.
2. Bolognia JL. A clinical approach to leukoderma. Int J Dermatol. 1999;38:568-723.
3. Gupta LK, Singhi MK. Wood's lamp. Indian J Dermatol Venereol Leprol. 2004;70:131-5.
4. Lai LG, Xu AE. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus. Skin Res Technol. 2011;17:404-10.
5. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-García L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647-52.
6. Boissy RE, Manga P. On the etiology of contact ⁄occupational vitiligo. Pigmentary Cell Research. 2004;17:208-14.
7. Bajaj AK, Saraswat A, Srivastav PK. Chemical leucoderma: Indian scenario, prognosis, and treatment. Indian J Dermatol. 2010;55:250-4.
8. Ghosh S, Mukhopadhyay S. Chemical leucoderma: A clinico-aetiological study of 864 cases in the perspective of a developing country. Br J Dermatol. 2009;160:40-7.
9. Teulings HE, Tjin EP, Willemsen KJ, Krebbers G, van Noesel CJ, Kemp EH, et al. Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: A case report and immunological analysis. Br J Dermatol. 2013;168:733-8.
10. Quaglino P, Marenco F, Osella-Abate S, Cappello N, Ortoncelli M, Salomone B, et al. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: Results from a single-institution hospital-based observational cohort study. Ann Oncol. 2010;21:409-14.
11. Arpaia N, Cassano N, Vena GA. Regressing cutaneous malignant melanoma and vitiligo-like depigmentation. Int J Dermatol. 2006;45:952-6.
12. Pandya AG. Top accessed article: Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol. 2012;148:1256.
13. Westerhof W, Relyveld GN, Kingswijk MM, de Man P, Menke HE. Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol. 2004;140:210-4.
14. Yang S, Makredes M, O'Donnell P, Levin NA. A case of Hansen disease presenting as tinea versicolor. Dermatol Online J. 2013;19:7.
15. Eichelmann K, González Gonzalez SE, Salas-Alanis JC, Ocampo-Candiani J Leprosy. An update: Definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr. 2013;104:554-63. Esta referencia está buena
16. Pandhi RK, Bedi TR, Bhutani LK. Leucoderma in early syphilis. Br J Vener Dis. 1977;53:19-22.
17. Gutiérrez-Pascual M, Vicente-Martín FJ, López-Estebaranz JL. Lichen sclerosus and squamous cell carcinoma. Actas Dermosifiliogr. 2012;103:21-8.
18. Monsálvez V, Rivera R, Vanaclocha F. Lichen sclerosus. Actas Dermosifiliogr. 2010;101:31-8.
19. Mimouni D, David M, Feinmesser M, Coire CI, Hodak E. Vitiligo-like leucoderma during photochemotherapy for mycosis fungoides. Br J Dermatol. 2001;145:1008-14.
20. Sánchez JL, Vázquez M, Sánchez NP. Vitiligo like macules in systemic scleroderma. Arch Dermatol. 1983;119:129-33.
21. Serup J. Clinical appearance of skin lesions and disturbances of pigmentation in localized scleroderma. Acta Derm Venereol. 1984;64:485-92.
22. Jawitz JC, Albert MK, Nigra TP, Bunning RD. A new skin manifestation of progressive systemic sclerosis. J Am Acad Dermatol. 1984;11:265-8.
23. Rai VM, Balachandran C. Pseudovitiligo in systemic sclerosis. Dermatol Online J. 2005;11:41.
24. Schmitt CE, Fabi SG, Kukreja T, Feinberg JS. Hypopigmented cutaneous sarcoidosis responsive to minocycline. J Drugs Dermatol. 2012;11:385-9.
25. Gautam M, Patil S, Munde P. Skin as a marker of internal disease: A case of sarcoidosis. Indian J Dermatol. 2011;56:439-41.
26. Arrunategui A, Trujillo RA, Marulanda MP, Sandoval F, Wagner A, Alzate A, et al. HLA-DQ3 is associated with idiopathic guttate hypomelanosis, whereas HLA-DR8 is not, in a group of renal transplant patients. Int J Dermatol. 2002;41:744-7.
27. Winship IM, Connor JM, Beighton PH. Genetic heterogeneity in tuberous sclerosis: Phenotypic correlations. J Med Genet. 1990;27:418-21.
28. Al-Dawsari NA, Shahab RK. Amyloidosis cutis dyschromia: A rare form of primary cutaneous amyloidosis. Dermatol Online J. 2014;20:223-8.
29. Kurian SS, Rai R, Madhukar ST. Amyloidosis cutis dyschromica Indian Dermatol Online J. 2013;4:344-6.
30. Eisenbarth GS, Gottlieb PA. Autoinmune polyendocrine syndrome. N Engl J Med. 2004;350:2068-79.
31. Cutolo M. Autoimmune polyendocrine síndromes. Autoimmun Rev. 2014;13:85-9.
2. Bolognia JL. A clinical approach to leukoderma. Int J Dermatol. 1999;38:568-723.
3. Gupta LK, Singhi MK. Wood's lamp. Indian J Dermatol Venereol Leprol. 2004;70:131-5.
4. Lai LG, Xu AE. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus. Skin Res Technol. 2011;17:404-10.
5. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-García L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647-52.
6. Boissy RE, Manga P. On the etiology of contact ⁄occupational vitiligo. Pigmentary Cell Research. 2004;17:208-14.
7. Bajaj AK, Saraswat A, Srivastav PK. Chemical leucoderma: Indian scenario, prognosis, and treatment. Indian J Dermatol. 2010;55:250-4.
8. Ghosh S, Mukhopadhyay S. Chemical leucoderma: A clinico-aetiological study of 864 cases in the perspective of a developing country. Br J Dermatol. 2009;160:40-7.
9. Teulings HE, Tjin EP, Willemsen KJ, Krebbers G, van Noesel CJ, Kemp EH, et al. Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: A case report and immunological analysis. Br J Dermatol. 2013;168:733-8.
10. Quaglino P, Marenco F, Osella-Abate S, Cappello N, Ortoncelli M, Salomone B, et al. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: Results from a single-institution hospital-based observational cohort study. Ann Oncol. 2010;21:409-14.
11. Arpaia N, Cassano N, Vena GA. Regressing cutaneous malignant melanoma and vitiligo-like depigmentation. Int J Dermatol. 2006;45:952-6.
12. Pandya AG. Top accessed article: Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol. 2012;148:1256.
13. Westerhof W, Relyveld GN, Kingswijk MM, de Man P, Menke HE. Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol. 2004;140:210-4.
14. Yang S, Makredes M, O'Donnell P, Levin NA. A case of Hansen disease presenting as tinea versicolor. Dermatol Online J. 2013;19:7.
15. Eichelmann K, González Gonzalez SE, Salas-Alanis JC, Ocampo-Candiani J Leprosy. An update: Definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr. 2013;104:554-63. Esta referencia está buena
16. Pandhi RK, Bedi TR, Bhutani LK. Leucoderma in early syphilis. Br J Vener Dis. 1977;53:19-22.
17. Gutiérrez-Pascual M, Vicente-Martín FJ, López-Estebaranz JL. Lichen sclerosus and squamous cell carcinoma. Actas Dermosifiliogr. 2012;103:21-8.
18. Monsálvez V, Rivera R, Vanaclocha F. Lichen sclerosus. Actas Dermosifiliogr. 2010;101:31-8.
19. Mimouni D, David M, Feinmesser M, Coire CI, Hodak E. Vitiligo-like leucoderma during photochemotherapy for mycosis fungoides. Br J Dermatol. 2001;145:1008-14.
20. Sánchez JL, Vázquez M, Sánchez NP. Vitiligo like macules in systemic scleroderma. Arch Dermatol. 1983;119:129-33.
21. Serup J. Clinical appearance of skin lesions and disturbances of pigmentation in localized scleroderma. Acta Derm Venereol. 1984;64:485-92.
22. Jawitz JC, Albert MK, Nigra TP, Bunning RD. A new skin manifestation of progressive systemic sclerosis. J Am Acad Dermatol. 1984;11:265-8.
23. Rai VM, Balachandran C. Pseudovitiligo in systemic sclerosis. Dermatol Online J. 2005;11:41.
24. Schmitt CE, Fabi SG, Kukreja T, Feinberg JS. Hypopigmented cutaneous sarcoidosis responsive to minocycline. J Drugs Dermatol. 2012;11:385-9.
25. Gautam M, Patil S, Munde P. Skin as a marker of internal disease: A case of sarcoidosis. Indian J Dermatol. 2011;56:439-41.
26. Arrunategui A, Trujillo RA, Marulanda MP, Sandoval F, Wagner A, Alzate A, et al. HLA-DQ3 is associated with idiopathic guttate hypomelanosis, whereas HLA-DR8 is not, in a group of renal transplant patients. Int J Dermatol. 2002;41:744-7.
27. Winship IM, Connor JM, Beighton PH. Genetic heterogeneity in tuberous sclerosis: Phenotypic correlations. J Med Genet. 1990;27:418-21.
28. Al-Dawsari NA, Shahab RK. Amyloidosis cutis dyschromia: A rare form of primary cutaneous amyloidosis. Dermatol Online J. 2014;20:223-8.
29. Kurian SS, Rai R, Madhukar ST. Amyloidosis cutis dyschromica Indian Dermatol Online J. 2013;4:344-6.
30. Eisenbarth GS, Gottlieb PA. Autoinmune polyendocrine syndrome. N Engl J Med. 2004;350:2068-79.
31. Cutolo M. Autoimmune polyendocrine síndromes. Autoimmun Rev. 2014;13:85-9.
Cómo citar
1.
Díaz CJ. Trastornos de hipopigmentación en adultos: generalidades y diagnósticos diferenciales. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 9 de agosto de 2019 [citado 20 de abril de 2024];22(3):235-42. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1051
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2019-08-09
Cómo citar
1.
Díaz CJ. Trastornos de hipopigmentación en adultos: generalidades y diagnósticos diferenciales. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 9 de agosto de 2019 [citado 20 de abril de 2024];22(3):235-42. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1051
Número
Sección
Revisión de tema
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
